Diethylpropion hydrochloride

Danegaptide Hydrochloride (GAP-134 Hydrochloride) is a potent, selective and orally active gap-junction modifier with an antiarrhythmic effectIn VitroDanegaptide (GAP-134, compound 9f: 0.01 nM-100 μM) dose dependently reduces dye uptake in cultured

Danegaptide Hydrochloride (GAP-134 Hydrochloride) is a potent, selective and orally active gap-junction modifier with an antiarrhythmic effectIn VitroDanegaptide (GAP-134, compound 9f: 0.01 nM-100 μM) dose dependently reduces dye uptake in cultured

Danegaptide Hydrochloride (GAP-134 Hydrochloride) is a potent, selective and orally active gap-junction modifier with an antiarrhythmic effectIn VitroDanegaptide (GAP-134, compound 9f: 0.01 nM-100 μM) dose dependently reduces dye uptake in cultured

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

An HCN Channel blocker: an open channel blocker of neuronal Ih and related cardiac If channels.Application：DK-AH 269 has been used as a hyperpolarization-activated and cyclic nucleotide-gated channel (HCN) antagonist to study its effects on the

An HCN Channel blocker: an open channel blocker of neuronal Ih and related cardiac If channels.Application：DK-AH 269 has been used as a hyperpolarization-activated and cyclic nucleotide-gated channel (HCN) antagonist to study its effects on the

An HCN Channel blocker: an open channel blocker of neuronal Ih and related cardiac If channels.Application：DK-AH 269 has been used as a hyperpolarization-activated and cyclic nucleotide-gated channel (HCN) antagonist to study its effects on the

An HCN Channel blocker: an open channel blocker of neuronal Ih and related cardiac If channels.Application：DK-AH 269 has been used as a hyperpolarization-activated and cyclic nucleotide-gated channel (HCN) antagonist to study its effects on the

An HCN Channel blocker: an open channel blocker of neuronal Ih and related cardiac If channels.Application：DK-AH 269 has been used as a hyperpolarization-activated and cyclic nucleotide-gated channel (HCN) antagonist to study its effects on the

Biochem/physiol Actions D-(or R-) enantiomer of &#945-hydroxyglutaric acid is a cancer related biomarker of diagnostic value, whereas the L-(or S-) enantiomer of &#945-hydroxyglutaric acid is a biomarker for certain neurometabolic, inherited

Biochem/physiol Actions D-(or R-) enantiomer of &#945-hydroxyglutaric acid is a cancer related biomarker of diagnostic value, whereas the L-(or S-) enantiomer of &#945-hydroxyglutaric acid is a biomarker for certain neurometabolic, inherited

ELN-441958 is a potent, neutral, competitive and selective bradykinin B 1 receptor antagonist with a K i of 0.26 nM against native human bradykinin B 1 receptor. ELN-441958 has high oral bioavailability, and has low CNS exposure in the mouseIn